RegeneRx Biopharmaceuticals Inc logo

RGRX - RegeneRx Biopharmaceuticals Inc News Story

$0.22 -0.0  -4.3%

Last Trade - 4:00pm

Sector
Healthcare
Size
Micro Cap
Market Cap £22.0m
Enterprise Value £22.4m
Revenue £55.1k
Position in Universe 5944th / 6852

BRIEF-Regenerx Joint Venture Expects To Complete Phase 3 Dry Eye Trial In November 2020

Mon 31st August, 2020 1:35pm
Aug 31 (Reuters) - RegeneRx Biopharmaceuticals Inc
 RGRX.PK :
    * REGENERX JOINT VENTURE EXPECTS TO COMPLETE PHASE 3 DRY EYE
TRIAL
IN NOVEMBER 2020

Source text for Eikon:  ID:nPn7Fnlvca 
Further company coverage:  RGRX.PK 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.